Status:
COMPLETED
Super 13 Pro & Prebiotics on the Human Intestinal Microflora
Lead Sponsor:
Cheng-Hsin General Hospital
Conditions:
Probiotics
Prebiotics
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into exp...
Detailed Description
This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into exp...
Eligibility Criteria
Inclusion
- Healthy adult volunteers and willing to give voluntary written informed consent
Exclusion
- Major systemic disease
- Pregnancy, parturient and feeding woman, or expect to be pregnant
- Abnormal liver function
- Abnormal renal function
- Abnormal gastrointestinal function
- Take medications for gastrointestinal and metabolic diseases
- Occurrences of severe diseases within 6 months, such as stroke, myocardial infarction, major trauma and surgery • Poor compliance for study protocol
Key Trial Info
Start Date :
October 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04043000
Start Date
October 21 2019
End Date
November 18 2019
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cheng Hsin General Hospital
Taipei, Taipei City, Taiwan, 112